Welcome

The Michigan Society of Hematology and Oncology (MSHO) is a non-profit 501c(6) corporation, formed in 1985 to address the growing needs of oncologists, radiation oncologists and hematologists in all practice settings in the state.

It is the Mission of MSHO to promote exemplary care for patients with cancer and/or blood disorders through advocacy, education and research.

Thank you to everyone who helped spread the word or donated blood at the MSHO and American Red Cross Blood Drive!

Blood Drive Thank You Image

To see the impact of the blood drive, click here.

Upcoming Events view all events

←	April 2021					→
S	M	T	W	T	F	S
				1	2 MSHO Office Closed April 2, 2021	3
4	5	6	7	8 COA 2021 Virtual Community Oncology Conference April 8-9, 2021	9 COA 2021 Virtual Community Oncology Conference April 8-9, 2021	10
11	12	13 Treatment Considerations in Polycythemia Vera and Myelofibrosis: Real-World Patient Case Discussion Presented by Incyte Flint, MI April 13, 2021 5:30-7:30PM Discover a New Treatment Option for Some Patients With Triple-Class Refractory Multiple Myeloma Presented by Oncopeptides A Virtual Event - Multiple Broadcast Times April 13-14, 2021 HOPA's Premier Hematology/Oncology Pharmacy Conference April 13-17, 2021	14 Discover a New Treatment Option for Some Patients With Triple-Class Refractory Multiple Myeloma Presented by Oncopeptides A Virtual Event - Multiple Broadcast Times April 13-14, 2021 HOPA's Premier Hematology/Oncology Pharmacy Conference April 13-17, 2021	15 A Treatment Option for Patients with Acute Myeloid Leukemia Presented by Bristol Myers Squibb A Virtual Event April 15, 2021 5:00-7:00PM American Red Cross & MSHO Blood Drive Charles H. Wright Museum - Detroit April 15, 2021 10:00AM-4:00PM HOPA's Premier Hematology/Oncology Pharmacy Conference April 13-17, 2021	16 HOPA's Premier Hematology/Oncology Pharmacy Conference April 13-17, 2021	17 HOPA's Premier Hematology/Oncology Pharmacy Conference April 13-17, 2021
18	19	20 Multidisciplinary Care Coordination for Breast Cancer Patients with CNS Metastases Presented by Michigan Medicine A Virtual Event April 20, 2021 5:30-7:30PM 46th Annual ONS Congress April 20-29, 2021	21 Intervening with Jakafi® (ruxolitinib) at Diagnosis in Patients with Intermediate-or High-Risk Myelofibrosis \| A Real World Patient Case Discussion Presented by Incyte Detroit, MI April 21, 2021 6:00-8:00PM MSHO Spring Reimbursement Meeting A Virtual Event April 21, 2021 8:00AM-12:30PM 46th Annual ONS Congress April 20-29, 2021	22 46th Annual ONS Congress April 20-29, 2021	23 46th Annual ONS Congress April 20-29, 2021	24 46th Annual ONS Congress April 20-29, 2021
25 46th Annual ONS Congress April 20-29, 2021	26 46th Annual ONS Congress April 20-29, 2021	27 46th Annual ONS Congress April 20-29, 2021	28 46th Annual ONS Congress April 20-29, 2021	29 46th Annual ONS Congress April 20-29, 2021	30